BRIEF-Stoke Therapeutics Q1 Operating Income USD 111.24 Million

Reuters
13 May
BRIEF-Stoke <a href="https://laohu8.com/S/LENZ">Therapeutics</a> Q1 Operating Income USD 111.24 Million

May 13 (Reuters) - Stoke Therapeutics Inc STOK.O:

  • STOKE THERAPEUTICS Q1 REVENUE USD 158.569 MILLION VERSUS. IBES ESTIMATE USD 7.61 MILLION

  • STOKE THERAPEUTICS Q1 OPERATING EXPENSES USD 47.329 MILLION

  • STOKE THERAPEUTICS Q1 NET INCOME USD 112.879 MILLION VERSUS. IBES ESTIMATE USD -25.3 MILLION

  • STOKE THERAPEUTICS Q1 OPERATING INCOME USD 111.24 MILLION VERSUS. IBES ESTIMATE USD -29.2 MILLION

Source text: ID:nBw7M09vLa

Further company coverage: STOK.O

((Reuters.Briefs@thomsonreuters.com;))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10